The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis
about
Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubsRelationship between triclosan and susceptibilities of bacteria isolated from hands in the communityCarboxylation mechanism and stereochemistry of crotonyl-CoA carboxylase/reductase, a carboxylating enoyl-thioester reductaseExposure of sink drain microcosms to triclosan: population dynamics and antimicrobial susceptibilityEssential Bacillus subtilis genesBacterial lipids: metabolism and membrane homeostasisCandida tropicalis expresses two mitochondrial 2-enoyl thioester reductases that are able to form both homodimers and heterodimersThe crystal structure of a mammalian fatty acid synthaseTriclosan Derivatives: Towards Potent Inhibitors of Drug-Sensitive and Drug-ResistantMycobacterium tuberculosisEffect of substrate binding loop mutations on the structure, kinetics, and inhibition of enoyl acyl carrier protein reductase from Plasmodium falciparumMode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI InhibitorDetermination of the Crystal Structure and Active Residues of FabV, the Enoyl-ACP Reductase from Xanthomonas oryzaeStructure of the Yersinia pestis FabV Enoyl-ACP Reductase and Its Interaction with Two 2-Pyridone InhibitorsStructural and Enzymatic Analyses Reveal the Binding Mode of a Novel Series of Francisella tularensis Enoyl Reductase (FabI) InhibitorsRational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (ACP) Reductase InhibitorCandida tropicalis Etr1p and Saccharomyces cerevisiae Ybr026p (Mrf1'p), 2-enoyl thioester reductases essential for mitochondrial respiratory competence.Resistance Mechanisms and the Future of Bacterial Enoyl-Acyl Carrier Protein Reductase (FabI) AntibioticsThe Halogen BondUsing modern tools to probe the structure-function relationship of fatty acid synthasesMechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureusVibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductaseMechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia malleiTriclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductaseDetermination of selectivity and efficacy of fatty acid synthesis inhibitors.Comprehensive identification of essential Staphylococcus aureus genes using Transposon-Mediated Differential Hybridisation (TMDH)Challenges of antibacterial discoveryCommunity-level assessment of dental plaque bacteria susceptibility to triclosan over 19 yearsCharacterization of protein redox dynamics induced during light-to-dark transitions and nutrient limitation in cyanobacteria.Response of Bacillus subtilis to cerulenin and acquisition of resistance.Discovery of a novel and potent class of F. tularensis enoyl-reductase (FabI) inhibitors by molecular shape and electrostatic matchingIdentification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductaseEssential genes in Bacillus subtilis: a re-evaluation after ten years.Mechanisms of bacterial biocide and antibiotic resistance.The impact of triclosan on the spread of antibiotic resistance in the environment.Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycleThe application of computational methods to explore the diversity and structure of bacterial fatty acid synthase.Screening of metagenomic and genomic libraries reveals three classes of bacterial enzymes that overcome the toxicity of acrylate.Perturbation and restoration of the fathead minnow gut microbiome after low-level triclosan exposure.Identification of a conserved protein involved in anaerobic unsaturated fatty acid synthesis in Neiserria gonorrhoeae: implications for facultative and obligate anaerobes that lack FabA.Is bacterial fatty acid synthesis a valid target for antibacterial drug discovery?
P2860
Q24562996-3D1EE6BC-6AF7-4848-978C-58676903B52BQ24564324-AC6C8BC7-4961-4558-BD39-16BBFDF95EE6Q24651556-936AB743-2E79-4258-B53B-6A026AC37B02Q24678992-4F5CF367-F0BF-47DB-9DBE-6E7781582C7EQ24681292-4135CE97-11D1-44EC-BA4B-7AAECFD909EDQ26829512-80EF4B93-F285-4BAB-B9DA-C18910034F95Q27641763-B68D4190-3530-4123-89CA-E50F627DD483Q27651988-805E3E28-9F0E-4D90-AF15-3011E6200A03Q27653366-A68ED4DD-783E-4372-9E11-D3A60299232AQ27666619-003E53E5-4327-4778-9286-A9ACA2F892D1Q27671875-8E615F52-54D7-4CE8-A911-7B3A1ABB48DCQ27675305-4A279BA8-1EF3-4EEB-82AD-347FBF777F92Q27676726-531A52AB-8929-4B30-87E2-048765EA4C20Q27679331-B1F9CFB8-4483-4CDB-98F1-9A279C27702DQ27683440-4A9ADA62-69C1-42F6-AB22-F02B25394EDBQ27937644-3DF786CB-C10D-4ECA-B6A4-EBA92C5EFEBBQ28069943-A410F9B3-C7E1-4768-9D6D-DEACDE578204Q28077775-2B99C9F5-A1A0-459C-A814-D5E6913016F8Q28080940-0746708E-15B9-4660-957C-599DE5AFF86BQ28485592-5D8E49DF-2706-4520-BBF7-D8C2FB36B1A9Q28485714-ACAF3DE6-3D1F-49CF-8B27-B7FB5647B11EQ28492113-ABEE04D4-B2C3-412F-9C23-A1E91BEAB0FEQ28492833-AA539154-4127-41CB-B21A-FBFDEC3F3620Q31123125-0C1AF793-9444-47B6-B17E-933E393C4FA0Q33477111-D9026CBC-0AD4-4DED-8353-A4444A76B78CQ33793074-0C405BCE-EF16-4786-A5F5-9C757B48EBBEQ33824705-D034D19B-713F-444A-9FD7-BA2F667F4525Q33842277-0372D3F8-761F-492A-82E9-29E3A34C13D5Q33996150-5ACCDC8F-0C26-4305-BE97-FC95A60F5833Q34078440-4AE49B7A-4045-4AC4-8CBE-233935FDE9D8Q34315832-D24CFBDA-C6D4-48F6-A091-CC117B2E2C41Q34328444-9D4C428B-4B3C-4BC7-B5A5-B77DD58C1026Q34631438-5E672F96-EF0A-4F57-90C8-C74D2491490BQ34969983-3DCE74CA-9EE6-414B-A2A6-48F9D762C1D0Q35023944-BCE8143A-FF9B-4549-92C6-033CAC9D2852Q35041188-7FBDB3BF-5128-4E68-9593-A190C1ACB080Q35171952-206B7829-8B3E-4ACC-9F35-3E4AAD43B140Q35219049-3CEA82FC-C7AE-4400-9265-A6F64E864E41Q35332481-D60D5123-910C-4310-9362-91B3B196E587Q35350186-BC39046B-7B2F-4B24-A174-0DA2703F2A9E
P2860
The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis
description
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2000
@ast
im Dezember 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/12/22)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/12/22)
@nl
наукова стаття, опублікована в грудні 2000
@uk
name
The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis
@ast
The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis
@en
The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis
@nl
type
label
The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis
@ast
The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis
@en
The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis
@nl
prefLabel
The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis
@ast
The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis
@en
The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis
@nl
P2093
P2860
P356
P1476
The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis
@en
P2093
P2860
P304
40128–40133
P356
10.1074/JBC.M005611200
P407
P577
2000-12-22T00:00:00Z